Preview

Антибиотики и Химиотерапия

Расширенный поиск
Доступ открыт Открытый доступ  Доступ закрыт Доступ платный или только для Подписчиков

Анализ спектра бактериальных патогенов, выделенных у пациентов с осложнёнными инфекциями кожи и мягких тканей, предположительно вызванными грамположительной или смешанной флорой, в странах Центральной и Восточной Европы

Полный текст:

Аннотация

Проведён анализ данных, включающих результаты микробиологических исследований клинического материала, полученного у пациентов с осложнёнными инфекциями кожи и мягких тканей, в 6 странах Европы. Результаты анализа спектра бактериальных патогенов позволяют получить представление о микробном пейзаже и эффективно проводить клинические исследования новых антибактериальных препаратов.

Об авторах

В. Н. Хохлова
PSI CRO AG, Цуг, Швейцария
Россия


А. А. Карелин
PSI CRO AG, Цуг, Швейцария
Россия


М. В. Белоцерковский
PSI CRO AG, Цуг, Швейцария
Россия


О. У. Стецюк
Смоленская государственная медицинская академия
Россия


Список литературы

1. Савельев В.С., Гельфанд Б.Р., Жуков А.В. с соавт. Хирургические инфекции кожи и мягких тканей. Российские национальные рекомендации. М.: Боргес, 2009.

2. Stevens D.L., Bisno A.L., Chambers H.F. et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections. Clin Infect Dis 2005, 41: 1373-1406.

3. Pallin D.J., Egan D.J., Pelletier A.J. et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008, 51: 291-298.

4. Rogers R.L., Perkins J. Skin and soft tissue infections. Prim Care 2006, 33: 697-710.

5. Dryden M.S. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009, 34: Suppl 1: S2-7.

6. Pulgar S., Mehra M., Quintana A., Kempel A. The epidemiology of hospitalized cases of skin and soft tissue infection in Europe. 18th European Congress of Clinical Microbiology and Infectious Diseases. 2008, Barcelona, Spain, Abstr. P821.

7. Doern G.V., Jones R.N., Pfaller M.A. et al. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 1999; 34: 65-72.

8. Jones M.E., Schmitz F.J., Fluit A.C. et al. Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an international surveillance program. Eur J Clin Microbiol Infect Dis. 1999; 18: 403-408.

9. Jones M.E., Karlowsky J.A., Draghi D.C. et al. Epidemiology and antibiotic susceptibility patterns of pathogens isolated from skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents. 2003; 22: 406-419

10. Bowler P.G., Duerden B.I., Armstrong D.G. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001; 14: 244-269.

11. Fung H.B., Chang J.Y., Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs. 2003; 63: 1459-1480.

12. Rennie R.P., Jones R.N., Mutnick A.H. et al. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn Microbiol Infect Dis. 2003; 45: 287-293.

13. Jodrá V.M., Pérez C.D., Soler L.S. et al. 2006. Results of the Spanish national nosocomial infection surveillance network (VICONOS) for surgery patients from January 1997 through December 2003. Am J Infect Control 2003; 34: 134-141.

14. May A.K., Stafford R.E., Bulger E.M. et al. Treatment of complicated skin and soft tissue infections. Surg Infect. 2009; 10: 5: 467-499.

15. Eron L.J., Lipsky B.A., Low D.E. et al. Expert panel on managing skin and soft tissue infections. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003; 52 Suppl 1: i3-17.

16. Moet G.J., Jones R.N., Biedenbach D.J. et al. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2007; 57: 7-13.

17. Sader H.S., Mallick R., Kuznik A. et al. Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections. Int J Antimicrob Agents. 2007; 30 : 6: 514-520.

18. Deresinski S. Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005; 40: 562-573.

19. Cosgrove S.E., Sakoulas G., Perencevich E.N. et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 2003; 36: 53-59.

20. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Uncomplicated and complicated skin and skin structure infections: Developing antimicrobial drugs treatment. Rockville, MD., 1998.

21. Sjolund M., Kahlmeter G. Staphylococci in primary skin and soft tissue infections in a Swedish county. Scand J Infect Dis. 2008; 40: 11-12: 894-898.

22. Shittu A., Lin J., Morrison D., Kolawole D. Isolation and molecular characterization of multiresistant Staphylococcus sciuri and Staphylococcus haemolyticus associated with skin and soft tissue infections. J Med Microbiol. 2004; 53: Pt 1: 51-55.

23. Cornia P.B., Davidson H.L., Lipsky B.A. The evaluation and treatment of complicated skin and skin structure infections. Expert Opin Pharmacother. 2008; 9: 5: 717-730.

24. Dhawan B., Gadepalli R., Kapil A. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India. Diagn Microbiol Infect Dis. 2009; 65: 2: 196-198.

25. Eagye K.J., Kim A., Laohavaleeson S. et al. Surgical site infections: does inadequate antibiotic therapy affect patient outcomes? Surg Infect (Larchmt). 2009; 10: 4: 323-331.

26. Owens R.C. Jr, Lamp K.C., Friedrich L.V., Russo R. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin. Am J Med 2007; 120: 10: Suppl 1: S6-12.

27. Jauregui L.E., Babazadeh S., Seltzer E. et al. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections. Clin Infect Dis 2005; 41: 10: 1407-1415.

28. European Antimicrobial Resistance Surveillance System (EARSS). EARSS Annual Report 2008. On-going surveillance of S.pneumoniae, S.aureus, E.coli, E.faecium, E.faecalis, K.pneumoniae, P.aeruginosa. http://www.rivm.nl/earss/Images/EARSS%202008_final_tcm61-65020.pdf

29. Lipsky B.A., Weigelt J.A., Gupta V., Killian A., Peng M.M. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol. 2007; 28: 11: 1290-1298.

30. Weigelt J., Itani K., Stevens D. et al. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. 2005; 49: 6: 2260-2266.


Для цитирования:


Хохлова В.Н., Карелин А.А., Белоцерковский М.В., Стецюк О.У. Анализ спектра бактериальных патогенов, выделенных у пациентов с осложнёнными инфекциями кожи и мягких тканей, предположительно вызванными грамположительной или смешанной флорой, в странах Центральной и Восточной Европы. Антибиотики и Химиотерапия. 2011;56(5-6):19-29.

For citation:


Khokhlova V.N., Karelin A.A., Belotserkovsky M.V., Stetsuk O.U. Analysis of the Spectrum of Bacterial Pathogens Isolated from Patients with Complicated Skin and Soft Tissue Infections Presumably Due to Grampositive or Mixed Flora in the Countries of the Central and East Europe. Antibiotics and Chemotherapy. 2011;56(5-6):19-29. (In Russ.)

Просмотров: 20


ISSN 0235-2990 (Print)